Route
SUBQ
Typical dose range
1 mg to 2.4 mg
Frequency
weekly
Half-life
7.5 days
Cycle on / off (days)
84 / 28
Evidence grade
B
Reconstitution math
Open the pre-filled Cagrilintide reconstitution calculator to compute syringe units per dose.
Reported Side Effects of Cagrilintide
Effects below are summarised from peer-reviewed literature or regulatory labeling where it exists. Not medical advice. Individual responses vary.
- Nausea, vomiting, and diarrhea, especially during dose titration DailyMed
- Constipation and early satiety DailyMed
- Injection-site reactions including redness and induration FDA label
- Gallbladder-related events (cholelithiasis, cholecystitis) reported in pivotal trials NEJM
- Risk of pancreatitis (discontinue if suspected) FDA label
- Contraindicated in personal or family history of medullary thyroid carcinoma or MEN 2 FDA boxed warning
Compare Cagrilintide
How Cagrilintide stacks up against the peers most users consider.